These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5013819)

  • 1. Spectral studies of the binding of O,O-diethyl p-nitrophenylphosphorothionate (parathion) to cytochrome P-450.
    Roth JA; Neal RA
    Biochemistry; 1972 Mar; 11(6):955-61. PubMed ID: 5013819
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of storage on hepatic microsomal cytochromes and substrate-induced difference spectra.
    Hewick DS; Fouts JR
    Biochem Pharmacol; 1970 Feb; 19(2):457-72. PubMed ID: 5507660
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation.
    Lu AY; Strobel HW; Coon MJ
    Biochem Biophys Res Commun; 1969 Aug; 36(4):545-51. PubMed ID: 4390187
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug metabolism by hepatic microsomes from phenobarbital-treated or starved male and female rats in the presence of inhibitors.
    Gigon PL; Bickel MH
    Life Sci II; 1971 Feb; 10(3):163-73. PubMed ID: 4252538
    [No Abstract]   [Full Text] [Related]  

  • 5. The incomplete conversion of hepatic cytochrome P-450 to P-420 by mercurials.
    Franklin MR
    Mol Pharmacol; 1972 Nov; 8(6):711-21. PubMed ID: 4344998
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease in the substrate interaction with cytochrome P-450 in drug hydroxylation by liver microsomes from rats bearing Walker 256 carcinosarcoma.
    Kato R; Takanaka A; Takahashi A
    Gan; 1970 Aug; 61(4):359-65. PubMed ID: 5454683
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-induced spectral change of liver microsomes in phenobarbital and methylcholanthrene-treated male and female rats.
    Kato R; Takanaka A; Takayanaghi M
    J Biochem; 1970 Sep; 68(3):395-413. PubMed ID: 5472352
    [No Abstract]   [Full Text] [Related]  

  • 9. Species differences in the effect of morphine administration or adrenalectomy on the substrate interactions with cytochrome P-450 and drug oxidations by liver microsomes.
    Kato R; Onoda KI; Takanaka A
    Biochem Pharmacol; 1971 Jun; 20(6):1093-9. PubMed ID: 5118111
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
    Sasame HA; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):123-30. PubMed ID: 4389182
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of binding in inhibition of hepatic microsomal metabolism by parathion and malathion.
    Stevens JT
    Life Sci; 1974 Jun; 14(11):2215-29. PubMed ID: 4847813
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between difference spectra and metabolism. Barbiturates, drug interaction and species difference.
    Topham JC
    Biochem Pharmacol; 1970 May; 19(5):1695-701. PubMed ID: 4398017
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.
    Gigon PL; Gram TE; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):109-22. PubMed ID: 4389181
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dietary protein quality on drug metabolism in the rat.
    Miranda CL; Webb RE
    J Nutr; 1973 Oct; 103(10):1425-30. PubMed ID: 4745519
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of thyroid hormone on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Takahashi A
    J Biochem; 1970 Nov; 68(5):613-23. PubMed ID: 5484443
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the nature of the type I and type II spectral changes in liver microsomes.
    Schenkman JB
    Biochemistry; 1970 May; 9(10):2081-91. PubMed ID: 4245596
    [No Abstract]   [Full Text] [Related]  

  • 17. The nature of the reverse type I (modified type II) spectral change in liver microsomes.
    Schenkman JB; Cinti DL; Orrenius S; Moldeus P; Kraschnitz R
    Biochemistry; 1972 Nov; 11(23):4243-51. PubMed ID: 5079897
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of magnesium and some other divalent cations on hepatic microsomal drug metabolism in vitro.
    Peters MA; Fouts JR
    Biochem Pharmacol; 1970 Feb; 19(2):533-44. PubMed ID: 4396251
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of drugs, steroids and fatty acids with liver-microsomal cytochrome P-450.
    Kupfer D; Orrenius S
    Eur J Biochem; 1970 Jun; 14(2):317-22. PubMed ID: 5506173
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of guinea pig liver and adrenal monooxygenase systems.
    Kupfer D; Orrenius S
    Mol Pharmacol; 1970 May; 6(3):221-30. PubMed ID: 4392663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.